In an effort to translate stem cell based ENb-TRAIL into clinical settings in brain tumor patients, we tested the efficacy of ENb-TRAIL in primary patient derived GBM cells in vitro and in vivo. The gene discussed is TNFSF10; the disease is glioblastoma.